Home » Topics » BioWorld Science

BioWorld Science
RSS

Xanodyne launches hycet

June 2, 2004

Biotronik enters distribution deal for Conor Medsystems' Costar stent

June 2, 2004

European MAA submitted for liquid Aricept

June 2, 2004

New ATS guidelines recommend use of tiotropium for COPD

June 2, 2004

Six months additional exclusivity for Agrylin

June 2, 2004

Metvix launch under way in Australia

June 2, 2004

Preclinical milestone reached in Neurogen/Merck & Co pain alliance

June 2, 2004

Farnesyltransferase inhibitor delays development of acute rejection

June 2, 2004

JAK-3 inhibition prevents obliterative bronchiolitis after tracheal transplantation

June 2, 2004

PG-490-88 prolongs survival in renal allograft models

June 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...